Log in to save to my catalogue

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheim...

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheim...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2634282085

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids

About this item

Full title

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids

Publisher

Cham: Springer International Publishing

Journal title

Molecular diversity, 2022-02, Vol.26 (1), p.489-503

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

A new series of quinolotacrine hybrids including cyclopenta- and cyclohexa-quinolotacrine derivatives were designed, synthesized, and assessed as anti-cholinesterase (ChE) agents. The designed derivatives indicated higher inhibitory effect on the acetylcholinesterase (AChE) with IC
50
values of 0.285–100 µM compared to butyrylcholinesterase (...

Alternative Titles

Full title

Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer’s disease: Quinolotacrine hybrids

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2634282085

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2634282085

Other Identifiers

ISSN

1381-1991

E-ISSN

1573-501X

DOI

10.1007/s11030-021-10307-2

How to access this item